nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000426	0.000426	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000424	0.000424	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000423	0.000423	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000422	0.000422	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000418	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000416	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Infection—Etoposide—peripheral nervous system neoplasm	0.000416	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000415	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000412	0.000412	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00041	0.00041	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000408	0.000408	CcSEcCtD
Gadobenate Dimeglumine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000407	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000406	0.000406	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000404	0.000404	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.000397	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000396	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000395	0.000395	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000394	0.000394	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000391	0.000391	CcSEcCtD
Gadobenate Dimeglumine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00039	0.00039	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000389	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000384	0.000384	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000381	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00038	0.00038	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000379	0.000379	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000376	0.000376	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000373	0.000373	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000372	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000372	0.000372	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00037	0.00037	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000368	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000367	0.000367	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000367	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000367	0.000367	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000364	0.000364	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000361	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Pain—Etoposide—peripheral nervous system neoplasm	0.000358	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000358	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000357	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.000354	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000353	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000352	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00035	0.00035	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000345	0.000345	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000344	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000343	0.000343	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000342	0.000342	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000341	0.000341	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000341	0.000341	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00034	CcSEcCtD
Gadobenate Dimeglumine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000338	0.000338	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000336	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000332	0.000332	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000331	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000331	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000328	0.000328	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Rash—Vincristine—peripheral nervous system neoplasm	0.000326	0.000326	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000325	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000324	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000324	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Headache—Vincristine—peripheral nervous system neoplasm	0.000323	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000318	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000312	0.000312	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000307	0.000307	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000302	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000301	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.0003	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000299	0.000299	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000299	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000298	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000297	0.000297	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000296	0.000296	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000295	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00029	0.00029	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000289	CcSEcCtD
Gadobenate Dimeglumine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000277	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000277	0.000277	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000273	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000271	0.000271	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000268	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000267	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Gadobenate Dimeglumine—Rash—Etoposide—peripheral nervous system neoplasm	0.000264	0.000264	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Gadobenate Dimeglumine—Headache—Etoposide—peripheral nervous system neoplasm	0.000262	0.000262	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00026	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000259	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000258	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000256	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000254	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000246	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000245	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000244	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000243	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000242	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00024	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000239	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000236	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000234	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000234	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000233	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000232	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000231	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00023	0.00023	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000228	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000227	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000225	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000224	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000221	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000219	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000219	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000217	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000216	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000214	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000213	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000213	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000212	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00021	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000209	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000208	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000206	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000203	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000202	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000202	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—peripheral nervous system neoplasm	0.0002	0.0002	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.0002	0.0002	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000198	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000193	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000193	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000193	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000192	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000191	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000187	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000187	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000186	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000186	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000186	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000185	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000185	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000179	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000177	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000173	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000172	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000171	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000171	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000168	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000166	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00016	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000156	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000155	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000153	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000149	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000147	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000143	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000139	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000138	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000137	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000137	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000136	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000129	CcSEcCtD
